ROP — Roper Technologies, Inc.

Near-term market sentiment is clearly positive: Q2 revenue of $2.11B beat expectations, organic growth was ~5%, adjusted EPS of $5.38 beat, and management raised full-year adjusted EPS guidance to $22.15-$22.30. The $1.2B Indicor sale proceeds, aggressive $1.2B Q2 buyback, and technical momentum reinforce the bid, but the stock is no longer washed out.

Revenue growth is decelerating from the mid-teen pace of mid-2025 to more sustainable high-single-digit growth: Q2 2026 revenue of $2.109B was +8.5% YoY versus Q1 2026 +11.3% and Q3 2025 +14.3%. Operating margins have been remarkably stable around 27-29% across the last 12 quarters, so this is a normalization, not deterioration. Q2 2026 GAAP EPS of $11.48 includes what appears to be a large non-operating gain—adjusted EPS was $5.38—so the reported line item should not be extrapolated. TTM free cash flow is roughly $2.62B, and the business remains a steady, high-margin compounder.

On trailing GAAP P/E of 17.5x, ROP looks misleadingly cheap because Q2 net income includes a one-off gain. More usefully, the stock trades at about 19.0x FY2026 adjusted EPS of $22.22, or roughly 19x consensus forward earnings. Versus its own 5-year average P/E of 39x and 5-year average P/S of 8.52x, the current 5.15x P/S and ~19x forward P/E are historically cheap; in absolute terms, 19x is a fair-to-attractive multiple for a high-quality recurring-revenue software business, though not a deep-value bargain.

The current price has already absorbed the good news from Q2 and the guidance raise—it sits right around the analyst consensus target of $427-$437. At roughly 19x forward earnings, the market is not pricing in aggressive growth or multiple expansion; it is pricing in delivery of the raised organic growth and EPS guide. If Roper hits its ~6% organic growth and $22.15-$22.30 EPS, a modest re-rating is plausible; if organic growth disappoints or M&A/Indicor execution stumbles, the low multiple can still compress because sentiment in software remains fragile.

As of 2026-08-27, RSI stood at 69.96, just below overbought, and price was +5.08% above the 20-day SMA, +13.21% above the 50-day SMA, and +12.13% above the 200-day SMA. The trend is clearly upward, but the stock is short-term extended; chasing a near-overbought RSI after a 30% bounce has poor risk/reward. A pullback toward the 20-day or 50-day moving average would offer a more attractive entry.

• Higher-for-longer interest rates have pressured long-duration software multiples; Roper's current forward P/E is a large de-rating from its own 5-year average.
• Generative AI disruption fears are causing investors to discount niche application software, though Roper's vertical workflows and mid-90s retention are defensive.
• Quality/defensive rotation benefits Roper because of its recurring revenue, stable margins, and strong FCF generation.
• Active M&A and buyback environment: the expected ~$1.2B Indicor cash proceeds plus steady FCF give Roper meaningful capital-deployment optionality.
• Enterprise software sector sentiment is recovering but still fragile, with investors rewarding visible growth and punishing deceleration.

• Q3 2026 earnings in late October, with management guiding to $5.75-$5.80 adjusted EPS.
• Closing of the Indicor/AMETEK transaction, expected to deliver ~$1.2B of post-tax cash proceeds.
• Continued aggressive share repurchases—$1.2B in Q2 alone at an average price near $341.
• Potential accretive M&A funded by the Indicor cash windfall.
• Next quarterly dividend of $0.91 per share on October 21, 2026.

• Organic growth decelerating below the low-to-mid single digits would undermine the recurring-revenue thesis.
• M&A execution or overpaying for assets could destroy value despite the high-quality track record.
• Further multiple compression in software if rates stay higher or AI disruption fears intensify.
• Leverage is moderate but debt/equity and a sub-1.0 current ratio leave limited balance-sheet buffer if FCF unexpectedly weakens.
• The GAAP EPS figure is distorted by one-off gains/amortization; relying on reported P/E rather than adjusted figures can mislead.

Roper is a high-quality, defensive software compounder with stable ~28% operating margins, strong FCF, and a reasonable ~19x forward multiple. The deterministic score says Fair Fundamentals, and my independent read agrees—this is not a deeply undervalued special situation, but it is also not an expensive one. The balanced risk/reward argues for holding existing positions and accumulating on a pullback rather than chasing the current near-overbought level.

Calculated by applying a 22x P/E multiple to FY2026 adjusted EPS of $22.22—a roughly 45% discount to Roper's 5-year average P/E of 39x, which I believe is appropriate given higher interest rates and ~6% organic growth. This is cross-checked against TTM FCF of ~$2.62B, implying a ~5.3% FCF yield at the fair price, a reasonable level for a high-quality compounder.